{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:26:43Z","timestamp":1786552003105,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.phrs.2022.106639","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T02:19:25Z","timestamp":1672193965000},"page":"106639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Augmented efficacy of nano-formulated docetaxel plus curcumin in orthotopic models of neuroblastoma"],"prefix":"10.1016","volume":"188","author":[{"given":"Martina","family":"Di Francesco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Pastorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Fragassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Di Francesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Lisa","family":"Palange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Celia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Di Marzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Cilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Bensa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirco","family":"Ponzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Decuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.phrs.2022.106639_bib1","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.phrs.2022.106639_bib2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/med.21750","article-title":"Molecular targeting therapies for neuroblastoma: progress and challenges","volume":"41","author":"Zafar","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2022.106639_bib3","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1038\/nrdp.2016.78","article-title":"Neuroblastoma","volume":"2","author":"Matthay","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"13","key":"10.1016\/j.phrs.2022.106639_bib4","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1200\/JCO.2001.19.13.3163","article-title":"Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study","volume":"19","author":"Mertens","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.phrs.2022.106639_bib5","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2022.106639_bib6","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1038\/nrdp.2016.78","article-title":"Neuroblastoma","volume":"2","author":"Matthay","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"8","key":"10.1016\/j.phrs.2022.106639_bib7","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.3390\/cancers12082057","article-title":"Targeting the tumor microenvironment in neuroblastoma: recent advances and future directions","volume":"12","author":"Joshi","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2022.106639_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fimmu.2018.00040","article-title":"Hypoxia pathway proteins as central mediators of metabolism in the tumor cells and their microenvironment","volume":"9","author":"Sormendi","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2022.106639_bib9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.phrs.2022.106639_bib10","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.molcel.2020.05.031","article-title":"Rational cancer treatment combinations: an urgent clinical need","volume":"78","author":"Boshuizen","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2022.106639_bib11","first-page":"7","article-title":"Combinatorial treatment of curcumin or silibinin with doxorubicin sensitises high-risk neuroblastoma","volume":"6","author":"Fonseka","year":"2020","journal-title":"J. Cancer Metastasis Treat."},{"issue":"3","key":"10.1016\/j.phrs.2022.106639_bib12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1158\/1078-0432.CCR-06-1908","article-title":"Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo","volume":"13","author":"Ponthan","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.phrs.2022.106639_bib13","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1002\/adfm.201500627","article-title":"Radiolabeled polymeric nanoconstructs loaded with docetaxel and curcumin for cancer combinatorial therapy and nuclear imaging","volume":"25","author":"Stigliano","year":"2015","journal-title":"Adv. Funct. Mater."},{"issue":"7","key":"10.1016\/j.phrs.2022.106639_bib14","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.nano.2016.05.012","article-title":"Spherical polymeric nanoconstructs for combined chemotherapeutic and anti-inflammatory therapies","volume":"12","author":"Lee","year":"2016","journal-title":"Nanomedicine"},{"issue":"20","key":"10.1016\/j.phrs.2022.106639_bib15","doi-asserted-by":"crossref","first-page":"7210","DOI":"10.1158\/0008-5472.CAN-04-1795","article-title":"Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo","volume":"64","author":"Johnsen","year":"2004","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.phrs.2022.106639_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3892\/ijmm.2014.2032","article-title":"Involvement of the nuclear factor-\u03baB signaling pathway in the regulation of CXC chemokine receptor-4 expression in neuroblastoma cells induced by tumor necrosis factor-\u03b1","volume":"35","author":"Zhi","year":"2015","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.phrs.2022.106639_bib17","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10585-014-9656-3","article-title":"COX2 expression in neuroblastoma increases tumorigenicity but does not affect cell death in response to the COX2 inhibitor celecoxib","volume":"31","author":"Bell","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.phrs.2022.106639_bib18","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.12659\/MSM.892597","article-title":"NF-\u03baB signaling pathway confers neuroblastoma cells migration and invasion ability via the regulation of CXCR4","volume":"20","author":"Zhi","year":"2014","journal-title":"Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res."},{"issue":"2B","key":"10.1016\/j.phrs.2022.106639_bib19","first-page":"987","article-title":"Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma","volume":"24","author":"Liontas","year":"2004","journal-title":"Anticancer Res."},{"issue":"1A","key":"10.1016\/j.phrs.2022.106639_bib20","first-page":"209","article-title":"Curcumin induces apoptosis in human neuroblastoma cells via inhibition of NF\u03baB","volume":"28","author":"Freudlsperger","year":"2008","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.phrs.2022.106639_bib21","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ejps.2011.02.009","article-title":"Curcumin activates Wnt\/\u03b2-catenin signaling pathway through inhibiting the activity of GSK-3\u03b2 in APPswe transfected SY5Y cells","volume":"42","author":"Zhang","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2022.106639_bib22","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3109\/10715762.2014.960410","article-title":"Curcumin induces apoptosis in human neuroblastoma cells via inhibition of AKT and Foxo3a nuclear translocation","volume":"48","author":"Picone","year":"2014","journal-title":"Free Radic. Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106639_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-015-0260-7","article-title":"Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity","volume":"15","author":"Liu","year":"2015","journal-title":"Cancer Cell Int."},{"issue":"5","key":"10.1016\/j.phrs.2022.106639_bib24","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1002\/jcp.27411","article-title":"Cyclooxygenase\u20102 in cancer: a review","volume":"234","author":"Hashemi Goradel","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106639_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/abbs\/gmr106","article-title":"Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer","volume":"44","author":"Yin","year":"2012","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"8","key":"10.1016\/j.phrs.2022.106639_bib26","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/cncr.21779","article-title":"Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors: a report from the Children's Oncology Group","volume":"106","author":"Zwerdling","year":"2006","journal-title":"Cancer: Interdiscip. Int. J. Am. Cancer Soc."},{"issue":"4","key":"10.1016\/j.phrs.2022.106639_bib27","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1200\/JCO.1997.15.4.1538","article-title":"Phase I trial of docetaxel administered as a 1-hinfusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial","volume":"15","author":"Blaney","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106639_bib28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/toxins2010128","article-title":"Curcumin\u2015the paradigm of a multi-target natural compound with applications in cancer prevention and treatment","volume":"2","author":"Teiten","year":"2010","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.phrs.2022.106639_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26265","article-title":"Docetaxel, bevacizumab, and gemcitabine for very high risk sarcomas in adolescents and young adults: a single-center experience","volume":"64","author":"Kuo","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2022.106639_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejon.2008.10.003","article-title":"Docetaxel-related side effects and their management","volume":"13","author":"Baker","year":"2009","journal-title":"Eur. J. Oncol. Nurs."},{"issue":"2","key":"10.1016\/j.phrs.2022.106639_bib31","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/jcb.21856","article-title":"Blockage of NF-kappaB by IKKbeta- or RelA-siRNA rather than the NF-kappaB super-suppressor IkappaBalpha mutant potentiates adriamycin-induced cytotoxicity in lung cancer cells","volume":"105","author":"Chen","year":"2008","journal-title":"J. Cell Biochem."},{"issue":"1","key":"10.1016\/j.phrs.2022.106639_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2008.03.025","article-title":"Curcumin and cancer: an \u201cold-age\u201d disease with an \u201cage-old\u201d solution","volume":"267","author":"Anand","year":"2008","journal-title":"Cancer Lett."},{"issue":"13","key":"10.1016\/j.phrs.2022.106639_bib33","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.7150\/thno.57828","article-title":"Recent progress in nanomedicine for enhanced cancer chemotherapy","volume":"11","author":"Wei","year":"2021","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.phrs.2022.106639_bib34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.118.255067","article-title":"Therapeutic opportunities in neuroblastoma using nanotechnology","volume":"370","author":"Rodr\u00edguez-Nogales","year":"2019","journal-title":"J. Pharm. Exp. Ther."},{"issue":"7","key":"10.1016\/j.phrs.2022.106639_bib35","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.nano.2016.05.012","article-title":"Spherical polymeric nanoconstructs for combined chemotherapeutic and anti-inflammatory therapies","volume":"12","author":"Lee","year":"2016","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"issue":"11","key":"10.1016\/j.phrs.2022.106639_bib36","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1021\/acsami.7b19136","article-title":"Hierarchical microplates as drug depots with controlled geometry, rigidity, and therapeutic efficacy","volume":"10","author":"Di Francesco","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.phrs.2022.106639_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-01993-9","article-title":"Cell surface nucleolin represents a novel cellular target for neuroblastoma therapy","volume":"40","author":"Brignole","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"20","key":"10.1016\/j.phrs.2022.106639_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201906426","article-title":"Combined replenishment of miR\u201034a and let\u20107b by targeted nanoparticles inhibits tumor growth in neuroblastoma preclinical models","volume":"16","author":"Di Paolo","year":"2020","journal-title":"Small"},{"issue":"22","key":"10.1016\/j.phrs.2022.106639_bib39","doi-asserted-by":"crossref","first-page":"7320","DOI":"10.1158\/1078-0432.CCR-08-0804","article-title":"Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin","volume":"14","author":"Pastorino","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"34","key":"10.1016\/j.phrs.2022.106639_bib40","doi-asserted-by":"crossref","first-page":"37943","DOI":"10.1021\/acsami.0c12202","article-title":"Modulating lipoprotein transcellular transport and atherosclerotic plaque formation in ApoE\u2013\/\u2013 mice via nanoformulated lipid\u2013methotrexate conjugates","volume":"12","author":"Di Francesco","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"21","key":"10.1016\/j.phrs.2022.106639_bib41","first-page":"7400","article-title":"Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy","volume":"63","author":"Pastorino","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2022.106639_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.biomaterials.2015.07.054","article-title":"Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusion","volume":"68","author":"Cossu","year":"2015","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.phrs.2022.106639_bib43","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/pi.5072","article-title":"Tuning core hydrophobicity of spherical polymeric nanoconstructs for docetaxel delivery","volume":"65","author":"Di Mascolo","year":"2016","journal-title":"Polym. Int."},{"key":"10.1016\/j.phrs.2022.106639_bib44","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3389\/fimmu.2017.01411","article-title":"Ameliorating amyloid-\u03b2 fibrils triggered inflammation via curcumin-loaded polymeric nanoconstructs","volume":"8","author":"Ameruoso","year":"2017","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2022.106639_bib45","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.3390\/ijms22115760","article-title":"Curcumin-loaded nanoparticles impair the pro-tumor activity of acid-stressed MSC in an in vitro model of osteosarcoma","volume":"22","author":"Di Pompo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.phrs.2022.106639_bib46","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.nano.2016.05.012","article-title":"Spherical polymeric nanoconstructs for combined chemotherapeutic and anti-inflammatory therapies","volume":"12","author":"Lee","year":"2016","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2022.106639_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol."},{"issue":"11","key":"10.1016\/j.phrs.2022.106639_bib48","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","article-title":"Smart cancer nanomedicine","volume":"14","author":"van der Meel","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"5","key":"10.1016\/j.phrs.2022.106639_bib49","doi-asserted-by":"crossref","first-page":"e991","DOI":"10.1016\/j.nano.2014.02.004","article-title":"Lipid\u2013polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells","volume":"10","author":"Palange","year":"2014","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"issue":"13","key":"10.1016\/j.phrs.2022.106639_bib50","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/smll.201303933","article-title":"Positron emitting magnetic nanoconstructs for PET\/MR imaging","volume":"10","author":"Aryal","year":"2014","journal-title":"Small"},{"issue":"15","key":"10.1016\/j.phrs.2022.106639_bib51","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.7150\/thno.18183","article-title":"Dexamethasone-loaded polymeric nanoconstructs for monitoring and treating inflammatory bowel disease","volume":"7","author":"Lee","year":"2017","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.phrs.2022.106639_bib52","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"issue":"4","key":"10.1016\/j.phrs.2022.106639_bib53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40005-019-00439-x","article-title":"Biocompatibility, biodegradation and biomedical applications of poly (lactic acid)\/poly (lactic-co-glycolic acid) micro and nanoparticles","volume":"49","author":"Elmowafy","year":"2019","journal-title":"J. Pharm. Invest."},{"issue":"12","key":"10.1016\/j.phrs.2022.106639_bib54","doi-asserted-by":"crossref","first-page":"12224","DOI":"10.1021\/acsnano.8b06021","article-title":"Erythrocyte-inspired discoidal polymeric nanoconstructs carrying tissue plasminogen activator for the enhanced lysis of blood clots","volume":"12","author":"Colasuonno","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2022.106639_bib55","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jconrel.2019.12.039","article-title":"Engineering shape-defined PLGA microPlates for the sustained release of anti-inflammatory molecules","volume":"319","author":"Di Francesco","year":"2020","journal-title":"J. Control Release"},{"issue":"2","key":"10.1016\/j.phrs.2022.106639_bib56","first-page":"235","article-title":"Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer","volume":"9","author":"Banerjee","year":"2017","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"10.1016\/j.phrs.2022.106639_bib57","doi-asserted-by":"crossref","first-page":"9703","DOI":"10.2147\/IJN.S274083","article-title":"Co-delivery of docetaxel and curcumin via nanomicelles for enhancing anti-ovarian cancer treatment","volume":"15","author":"Hu","year":"2020","journal-title":"Int J. Nanomed."},{"issue":"1","key":"10.1016\/j.phrs.2022.106639_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12645-022-00119-w","article-title":"Synergistic co-administration of docetaxel and curcumin to chemoresistant cancer cells using PEGylated and RIPL peptide-conjugated nanostructured lipid carriers","volume":"13","author":"Kim","year":"2022","journal-title":"Cancer Nanotechnol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822005850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822005850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:38:02Z","timestamp":1760913482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822005850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":58,"alternative-id":["S1043661822005850"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106639","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Augmented efficacy of nano-formulated docetaxel plus curcumin in orthotopic models of neuroblastoma","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106639","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106639"}}